 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
9-6-2023
Insider Buy |
Robert G. Adams
Director |
$66.96
CAGR »
|
$133,923.60
2,000 shares |
8-9-2023
Insider Buy |
W. Andrew Adams
Director |
$67.17
CAGR »
|
$125,000.95
1,861 shares |
6-29-2023
Insider Buy |
Richard F. Laroche Jr.
Director |
$61.40
CAGR »
|
$128,944.20
2,100 shares |
5-15-2023
Insider Buy |
Ernest G. Burgess III
Director |
$58.85
CAGR »
|
$135,350.17
2,300 shares |
2-23-2023
Insider Buy |
James Paul Abernathy
Director |
$57.45
CAGR »
|
$125,011.20
2,176 shares |
9-22-2020
Insider Buy |
Richard F. Laroche Jr.
Director |
$60.93
CAGR »
|
$29,062.18
477 shares |
8-22-2011
Insider Buy |
W. Andrew Adams
Director |
$32.10
CAGR »
|
$642,000.00
20,000 shares |
8-9-2011
Insider Buy |
Robert G. Adams
CEO |
$31.76
CAGR »
|
$63,520.00
2,000 shares |
Also See: Institutional Holders of NHC
Also See: SEC filings
Below we present the annualized performance delivered by National Healthcare stock since 9-6-2023 (the date of the most recent
insider purchase). The performance of the investment from the time National Healthcare insider buying occurred is the ultimate
test of whether insiders were right about NHC being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
09/07/2023 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$65.72 |
|
| End price/share: |
$89.99 |
|
| Starting shares: |
152.16 |
|
| Ending shares: |
155.48 |
|
| Dividends reinvested/share: |
$1.77 |
|
| Total return: |
39.91% |
|
| Annualized Gain: |
63.90% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,991.00 |
|
| Years: |
0.62 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/07/2023 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$65.72 |
|
| End price/share: |
$89.99 |
|
| Dividends collected/share: |
$1.77 |
|
| Total return: |
39.62% |
|
| Annualized Gain: |
63.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,962.00 |
|
| Years: |
0.62 |
|
National Healthcare Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent National Healthcare insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NHC
|
|
Free NHC Email Alerts:
